Publications

2017

Mereu E, Pellegrino E, Scarfò I, Inghirami G, Piva R. The heterogeneous landscape of ALK negative ALCL. Oncotarget. 2017;8(11):18525-18536.
Khani F, Robinson BD. Precursor Lesions of Urologic Malignancies. Arch Pathol Lab Med. 2017;141(12):1615-1632.
Abate F, da Silva-Almeida AC, Zairis S, Robles-Valero J, Couronne L, Khiabanian H, et al. Activating mutations and translocations in the guanine exchange factor VAV1 in peripheral T-cell lymphomas. Proc Natl Acad Sci U S A. 2017;114(4):764-769.
Nuovo GJ, Folcik VA, Magro C. Viral-induced Modulation of Multiple Checkpoint Proteins in Cancers. Appl Immunohistochem Mol Morphol. 2017;25(6):407-414.
Ely S, Forsberg P, Ouansafi I, Rossi A, Modin A, Pearse R, et al. Cellular Proliferation by Multiplex Immunohistochemistry Identifies High-Risk Multiple Myeloma in Newly Diagnosed, Treatment-Naive Patients. Clin Lymphoma Myeloma Leuk. 2017;17(12):825-833.
Marcus A, Koizumi J, Robinson B, Giorgadze T. Perihepatic cystic mass: Zebra or horse? Cytojournal. 2017;14:21.
Brown KA, Iyengar NM, Zhou XK, Gucalp A, Subbaramaiah K, Wang H, et al. Menopause Is a Determinant of Breast Aromatase Expression and Its Associations With BMI, Inflammation, and Systemic Markers. J Clin Endocrinol Metab. 2017;102(5):1692-1701.
Meehan TF, Conte N, Goldstein T, Inghirami G, Murakami MA, Brabetz S, et al. PDX-MI: Minimal Information for Patient-Derived Tumor Xenograft Models. Cancer Res. 2017;77(21):e62-e66.
Sun Q, Calderon B, Zhao Z. Discrepancies between two immunoassays for the determination of MPO and PR3 autoantibodies. Clin Chim Acta. 2017;470:93-96.
Solomon JP, Lowenthal BM, A Kader K, J Parsons K, Flaig TW, Siefker-Radtke AO, et al. Challenges in the Diagnosis of Urothelial Carcinoma Variants: Can Emerging Molecular Data Complement Pathology Review? Urology. 2017;102:7-16.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700